These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 3045699

  • 1. Alkylation of striatal dopamine receptors abolishes stereotyped behavior but has no effect on dopamine stimulated adenylate cyclase activity.
    Cameron DL, Crocker AD.
    Neurosci Lett; 1988 Jul 19; 90(1-2):165-71. PubMed ID: 3045699
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Differential modification of striatal D1 dopamine receptors and effector moieties by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo and in vitro.
    Hess EJ, Battaglia G, Norman AB, Creese I.
    Mol Pharmacol; 1987 Jan 19; 31(1):50-7. PubMed ID: 3100940
    [Abstract] [Full Text] [Related]

  • 4. Localization of striatal dopamine receptor function by central injection of an irreversible receptor antagonist.
    Cameron DL, Crocker AD.
    Neuroscience; 1989 Jan 19; 32(3):769-78. PubMed ID: 2601845
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Functional recovery of D1 dopamine receptor-mediated stimulation of rat striatal adenylate cyclase activity following irreversible receptor modification by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ): evidence for spare receptors.
    Battaglia G, Norman AB, Hess EJ, Creese I.
    Neurosci Lett; 1986 Sep 12; 69(3):290-5. PubMed ID: 2945128
    [Abstract] [Full Text] [Related]

  • 7. Behavioral recovery after irreversible inactivation of D-1 and D-2 dopamine receptors.
    Meller E, Bordi F, Bohmaker K.
    Life Sci; 1989 Sep 12; 44(15):1019-26. PubMed ID: 2564615
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
    Thomas KL, Rose S, Jenner P, Marsden CD.
    Biochem Pharmacol; 1992 Jul 07; 44(1):83-91. PubMed ID: 1321631
    [Abstract] [Full Text] [Related]

  • 10. Effect of aging on striatal dopamine receptor subtype recovery following N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline blockade and relation to motor function in Wistar rats.
    Henry JM, Joseph JA, Kochman K, Roth GS.
    Brain Res; 1987 Aug 25; 418(2):334-42. PubMed ID: 2960421
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Persistent increase in striatal dopamine stimulated adenylate cyclase activity persists for more than 6 months but disappears after 1 year following withdrawal from 18 months cis-flupenthixol intake.
    Murugaiah K, Fleminger S, Theodorou A, Jenner P, Marsden CD.
    Biochem Pharmacol; 1983 Sep 01; 32(17):2495-9. PubMed ID: 6684429
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Behavioral and radioligand binding evidence for irreversible dopamine receptor blockade by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.
    Hamblin MW, Creese I.
    Life Sci; 1983 May 09; 32(19):2247-55. PubMed ID: 6133202
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of ceruletide on perioral movements and the dopamine receptor-adenylate cyclase system in rats chronically treated with fluphenazine.
    Ashizawa T, Saito T, Takahata N.
    Psychopharmacology (Berl); 1996 Jun 09; 125(3):185-94. PubMed ID: 8815952
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.